Article Details

Nouscom receives approval to begin Phase 1b trials of NOUS-PEV, a novel personalized cancer ...

Retrieved on: 2021-03-11 07:41:15

Tags for this article:

Click the tags to see associated articles and topics

Nouscom receives approval to begin Phase 1b trials of NOUS-PEV, a novel personalized cancer .... View article details on hiswai:

Excerpt

Each of the two viral vector systems encodes multiple personalized ... to the immune system and promote potent and broad immune responses.

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up